Inovio Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
08/19

DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. $(INO)$ rose 4.35% to $1.20 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 1.33% to 26,289.71 and Dow Jones Industrial Average falling 0.22% to 53,343.40.

This was the stock's seventh consecutive day of gains.

Inovio Pharmaceuticals Inc. closed 59.72% short of its 52-week high of $2.98, which the company achieved on September 9th.

The stock outperformed some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 3.33% to $271.11, Statera Biopharma Inc. (STAB) fell 50.00% to $0.00, and Pfizer Inc. $(PFE)$ rose 1.41% to $27.25.

Trading volume (4.7 M) eclipsed its 50-day average volume of 3.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2026.

 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10